Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. - Wikidata - wikimedia - TriplyDB

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

http://www.wikidata.org/entity/Q34112602

about

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu Improving the clinical impact of biomaterials in cancer immunotherapy.Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy Materials based tumor immunotherapy vaccines Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Particle-mediated delivery of cytokines for immunotherapy Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Enhancement of biological reactions on cell surfaces via macromolecular crowding.Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing Improving cell-based therapies by nanomodification Micro and nanoparticle drug delivery systems for preventing allotransplant rejection Synthetic Nanoparticles for Vaccines and Immunotherapy Cell delivery of therapeutic nanoparticles Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice Design strategies and applications of circulating cell-mediated drug delivery systems Obtaining control of cell surface functionalizations via Pre-targeting and Supramolecular host guest interactions A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells.Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy Tumor lysing genetically engineered T cells loaded with multi-modal imaging agents Shedding light on nanomedicine.Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal.Organic/inorganic double-layered shells for multiple cytoprotection of individual living cells.In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.Cancer targeted therapeutics: From molecules to drug delivery vehicles.T cells enhance gold nanoparticle delivery to tumors in vivo.Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.Click hybridization of immune cells and polyamidoamine dendrimers Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.Transferrin coated nanoparticles: study of the bionano interface in human plasma.Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity.Enhanced Transport Capabilities via Nanotechnologies: Impacting Bioefficacy, Controlled Release Strategies, and Novel Chaperones.Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy.Engineering cells with intracellular agent-loaded microparticles to control cell phenotype.Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.

P2860

Q21131200-3F46606D-F220-4477-A60B-8A9FAD13BCCE Q26766267-6852F0B8-6F86-40E6-A2A3-FF69D39F079E Q26782566-A7E94E20-6770-46EF-A046-A1FA9B903707 Q26824135-12C9BA61-DA0B-4B4C-87BB-D7DAACEBC916 Q26830028-07A9B952-CD75-4577-BDD6-584DC3265A91 Q26997993-D9D47FE6-14A0-4013-ABF4-9D9103361346 Q27002209-8FE845F5-6377-4DBE-9373-33D57C86F4FE Q27324653-6D90C859-B4FD-431D-B7E0-A74E21589675 Q27334215-F48C6491-1DAF-405D-B3F5-829946D8F8BC Q28080427-EF0CB77C-11F0-4C1A-BCF5-6C5E6EA35D03 Q28080720-AD778136-FE6C-4611-BFB9-9C797282569B Q28085375-3DD83A10-9ED9-4F3F-BFBC-EB05F714346C Q28385606-8D8D66AB-608B-4616-A45E-1E9145AC4850 Q28486624-4A346E33-F5A1-49E5-98E1-B3951820606D Q28547179-A5F158BC-9C19-4C55-8F8C-92E6746BE167 Q28817957-E438B6AC-F434-4757-BC4D-14DEFCEFC76F Q30385378-3285DA0C-7168-4CA0-9626-8352B641766E Q30415766-0F6FDFFE-D1AD-43EE-928C-7641E60D692C Q30421156-D6FDC08B-90AE-4191-A5B5-19FA07EA4DBF Q30441151-D7204539-3F76-4D44-A281-E9BC7AC57252 Q30447871-B7A6B1C5-5349-44D4-92D7-9261322EFE29 Q30577136-1055938A-0B18-4246-B591-F148DB7392DA Q33691602-466F0DF3-5ABE-49F4-AC76-95B4B3F55F68 Q33716478-34CB578A-AB17-4984-9C9D-5E873E3760E4 Q33772783-405F095B-9A01-496C-B77C-EC47748DA712 Q33815087-AE4AF383-A511-4B27-A2C2-8F21E2ACB3EA Q33864915-765A5EBF-E2DA-4AE0-A9D3-6F711589B428 Q33887986-CCE74C45-5C77-4D17-B3E9-9B078C201B7F Q33945027-8E24EB5B-7DB1-4092-8FC5-7CDB26C905A7 Q34028841-9A8ABFE3-31EB-413B-91E7-A0486CD76B22 Q34030709-DD4BFA97-8BAC-49AD-9CB8-63DD3CD87424 Q34047132-862AE433-48F4-4DC4-B0C0-1AAB720D6FC4 Q34079604-14078E84-1838-4358-A229-A2A695F5BA20 Q34351046-AA4B6810-3E20-4561-B1C6-93DA41174D9F Q34596348-3A759245-ACA1-42E9-A314-B2458A3826DA Q34763957-28D2E98B-8C99-4A78-BD3A-FF0816C99C9E Q34983770-1F62DB72-A502-42C6-A561-6CEF8E047703 Q35053924-1C8EED6E-A894-423E-A44F-1F6A02960C39 Q35060703-E06F8CC4-C1D3-4796-8D2C-F6D00122394D Q35142623-4CBDFE8E-6631-4B6C-B35B-AE29317589FC

P2860

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

http://www.wikidata.org/entity/Q34112602

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@ast

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@en

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@nl

type

label

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@ast

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@en

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@nl

prefLabel

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@ast

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@en

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@nl

P1433

Q34112602-B2898E6D-CACE-4D1E-9DB4-57EDDFC9EBB4

P1476

Q34112602-3054F83D-3650-440C-A0F3-3D8A84D7463C

P2093

Q34112602-095B12B4-875B-48E0-8E5E-2225216F9C9F

Q34112602-1856FFD6-C80A-4A8E-8110-6DCBE87F8130

Q34112602-42C97D4C-888F-4A58-B11D-0E29374B1B3A

Q34112602-A87B470A-A61D-4E4D-B272-E8A81026E241

Q34112602-FD41A816-DEF3-420A-B038-669B659F6C72

P2860

Q34112602-02C2E78B-25E5-49E3-B169-C9F2AFA276B8

Q34112602-1682C867-4CF3-4D1D-BF34-B24C523497AF

Q34112602-188458E0-7FCA-42CA-A9D1-4B1A41094C14

Q34112602-1A9CFD09-BACD-4252-B597-12ECDDE142E4

Q34112602-3DA4FEE7-5EA4-4CC2-8373-AF3F811468E3

Q34112602-470DCFD2-2AC1-4B78-B296-762FB5FC32FF

Q34112602-481E9CC0-361E-4B16-BACE-CADF3D2F91DA

Q34112602-495D8E88-11D0-4188-B184-CC44F25EE2A2

Q34112602-49B63D74-CD6B-485B-A419-EACC99B838BB

Q34112602-4F87711E-2126-41E0-933A-F5FE0A6DCF93

P2888

Q34112602-946C5D18-200E-4525-877A-626EC8751DFC

P304

Q34112602-67E7619D-7B8C-455C-83A2-CAD7AB450AD5

P31

Q34112602-9609DDFE-4B7B-416C-8B7E-E8F8F08B6701

P356

Q34112602-07283A30-FB91-4E54-B103-D0699705C953

P407

Q34112602-637EEB04-0217-491C-97F7-3CAA1480859D

P433

Q34112602-87FB2182-96B6-424A-85F8-87C199ECE96B

P478

Q34112602-78A992E4-F050-4087-AE38-CE1F73E8BF38

P577

Q34112602-89757302-791E-471E-BF86-4492569817AB

P5875

Q34112602-A558B264-1405-49CA-8BFE-144FCE3EE9C2

P698

Q34112602-2CF49716-AEAB-464E-A98F-F8934F8C187F

P921

Q34112602-309E747B-EFC1-4DE3-AED1-9BF55D50486F

P932

Q34112602-2CF135B1-64DA-4EAD-9CB9-A7FABD9442E9

P356

P1433

Nature Medicine

P1476

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

@en

P2093

Anna Bershteyn

http://www.w3.org/2001/XMLSchema#string

Darrell J Irvine

http://www.w3.org/2001/XMLSchema#string

James J Moon

http://www.w3.org/2001/XMLSchema#string

Matthias T Stephan

http://www.w3.org/2001/XMLSchema#string

Soong Ho Um

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells

Cancer regression in patients after transfer of genetically engineered lymphocytes

Chemical remodelling of cell surfaces in living animals

Nanoparticle therapeutics: an emerging treatment modality for cancer

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.

Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules.

Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}

P2888

P304

1035-1041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2198

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45651105

http://www.w3.org/2001/XMLSchema#string

P698

20711198

http://www.w3.org/2001/XMLSchema#string

P921

P932

2935928

http://www.w3.org/2001/XMLSchema#string